Nguyen D, Jabbour E, Kantarjian HM, Macaron W, Jain N, Nasnas C, Kebriaei P, Shpall EJ, Khouri I, Haddad F, Karrar O, Maroun M, Garris R, Ravandi F, Short NJ. Impact of high-sensitivity next-generation sequencing measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRDpositive B-cell acute lymphoblastic leukemia. Haematologica [Internet]. 2026Nov.1 [cited 2026Nov.13];111(11):3785-9. Available from: https://haematologica.org/article/view/13422